Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
myeloid leukemia (DSPII) Control of chromosome segregation during early development in mammals Development and characterization of a pig model for the study of Usher syndrome type 2C (USH2C) From Signal
-
celebrating its 20th anniversary in 2026, entering a new and exciting phase of its development for the next ten years. Adopting a new higher education model based on the concept of Syntegrative Education (SE
-
-collection costs while maintaining validity for marketing and opinion research. Design, implement, and evaluate large-language-model (LLM) pipelines for synthetic data (fine-tuning, retrieval-augmented
-
to join our research team for a project focused on battery modelling, state estimation, fault diagnosis and control. Information Batteries are at the core of the sustainable energy transition by powering
-
), funded by Ministerio de Ciencia, Innovación y Universidades/AEI, focused on ‘Continual Learning for Foundation Models’ where the aim is to adapt foundation models to new tasks without forgetting previous
-
available until filled. To apply, please visit: https://wcmq-academicpositions.odoo.com/jobs/postdoctoral-associate-mathematical-modeling-of-communicable-and-non-communicable-diseases-107?utm_campaign=Job
-
Model for Integration of Advanced Assistive Technologies (ROBOWELL )”, funded by NordForsk and Novo Nordic Foundation (grant agreement 226198). The project aims to develop a proposal for a Nordic Model
-
-site) appointments FLEXIBILITY: Flexible working time models, including options close to full-time ( https://go.fzj.de/near-full-time ), allow you to tailor your working hours to suit your individual
-
business model. In its research approach, the UM6P promotes transdisciplinary, entrepreneurship spirit and collaboration with external institutions for developing up to date science and at continent level in
-
adequately to available treatments. There is a pressing need for novel disease modifying treatments. At present anti-rheumatic drug development still relies on simplified in vitro model systems and on animal